Epithalon, also spelled Epitalon, is a peptide investigated in telomere and cell research. Cell findings can guide further research but do not establish that a product extends human lifespan or reverses ageing.
What the research shows
A 2003 study examined telomerase and telomere length in cultured fibroblasts. A 2025 paper also studied cell lines and has a subsequent correction notice, which should be read alongside it. Neither is a human lifespan trial. [1] [2] [3] [4] [5]
Related substances appeared on the FDA’s 2026 compounding agenda; this is not product approval. [5]
Distinguishing substances and products
Epithalon and Epitalon are useful search variants, but the actual label still needs checking. Longevity wording or a purity result does not establish an anti-ageing benefit for a product.
Reading a specific brand’s label
Start with the exact substance and product name, then match the label to the manufacturer’s documents. This article does not establish Thai registration or current availability for an unspecified product.
Frequently asked questions
Are Epithalon and Epitalon different names?
They are spelling variants used for this peptide; matching a product still requires its label and documents.
Do cell telomere changes prove longer human life?
No. That claim requires relevant human outcome evidence.
What information helps identify a specific product?
The brand, product name, full label and matching manufacturer documents. Evidence about the substance alone does not establish a product’s identity, registration or quality.
Related information
For general questions about names or label details, contact LINE: @musclestationth
Sources and review date
- Cultured fibroblast study, 2003
- Epitalon cell-line study, 2025
- Correction to the 2025 study
- Publisher correction — full text
- FDA — 2026 PCAC agenda
Sources checked: 11 September 2026. This page explains selected primary sources; it is not a systematic review of every study.